SCHEMBL17878

SCHEMBL17878

O=S(=O)(c1cccs1)N1CCN(c2ccc(C(O)(CF)C(F)F)cc2)[C@H](CN2CCOCC2)C1

nearest known ligand 0.77

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 10/20 0.77
GCK P35557 10/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17514 0.90 GCKR (0.62) GCKRGCK
SCHEMBL21458 0.89 GCK (0.77) GCKRGCK
SCHEMBL16144 0.89 GCKR (0.60) GCKRGCK
SCHEMBL16129 0.89 GCKR (0.77) GCKRGCK
SCHEMBL16527 0.89 GCKR (0.77) GCKRGCK
SCHEMBL21504 0.88 GCKR (0.59) GCKRGCK
SCHEMBL17018 0.88 GCKR (0.59) GCKRGCK
SCHEMBL16425 0.87 GCKR (0.62) GCKRGCK
SCHEMBL16197 0.87 GCKR (0.62) GCKRGCK
SCHEMBL12089476 0.87 GCKR (0.81) GCKRGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed